Sugi Predict

Sugi Predict / Compounds / SCHEMBL3100766

SCHEMBL3100766

SCHEMBL3100766

CCN(C(=O)C(Cc1ccc(C)c(NC(=O)c2ccccc2)c1)C(=O)NS(=O)(=O)/C=C/c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAF1 P04049 1/20 0.40
▸ HDAC1 Q13547 2/20 0.38
▸ HDAC6 Q9UBN7 2/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ MAPK14 Q16539 5/20 0.35
▸ BCHE P06276 1/20 0.35
▸ ACHE P22303 1/20 0.34
▸ POLB P06746 2/20 0.34
▸ SMO Q99835 1/20 0.34
▸ HPGD P15428 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ SNCA P37840 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3100776 1.00 RAF1 (0.40) RAF1HDAC1HDAC6HDAC8ALDH1A1
SCHEMBL3091649 0.88 LMNA (0.39) HDAC1HDAC6ALDH1A1HPGDHTT
SCHEMBL3091640 0.88 LMNA (0.39) HDAC1HDAC6ALDH1A1HPGDHTT
SCHEMBL3093966 0.86 POLB (0.38) HDAC1HDAC6ALDH1A1POLBHTT
SCHEMBL3093978 0.86 POLB (0.38) HDAC1HDAC6ALDH1A1POLBHTT
SCHEMBL3096530 0.83 ALDH1A1 (0.40) ALDH1A1KDM4EPOLBHPGDHTT
SCHEMBL3096541 0.83 ALDH1A1 (0.40) ALDH1A1KDM4EPOLBHPGDHTT
SCHEMBL3083962 0.83 KMT2A (0.45) HDAC1HDAC6ALDH1A1POLBHPGD
SCHEMBL3083960 0.83 KMT2A (0.45) HDAC1HDAC6ALDH1A1POLBHPGD
SCHEMBL3092616 0.82 HTT (0.41) RAF1HDAC1HDAC6HDAC8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2172450-B9 NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2014-10-08 — — EP disclosed
EP-2172450-B1 NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2013-10-16 — — EP disclosed
US-8461209-B2 Malonic acid sulfonamide derivative and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-06-11 — — US disclosed
US-20100228026-A1 NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-09-09 — — US disclosed
EP-2172450-A1 NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2010-04-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100228026-A1 NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF REN, AGTR2, AGTR1 RAF1 500/4885HDAC1 1764/4885HDAC6 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.